Cumberland Pharmaceuticals CPIX

$ 2.4 -0.83%

Quarterly report 2024-Q3
added 11-08-2024

Cumberland Pharmaceuticals Balance Sheet 2011-2024 | CPIX

Annual Balance Sheet Cumberland Pharmaceuticals

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-15 M	-26 M	-7.57 M	-6.72 M	352 K	-30.9 M	-14.8 M	-21.9 M	-39.9 M	-40.9 M	-33.3 M	-65.7 M
Long Term Debt	4.59 M	90 K	15 M	18.5 M	20 M	9.8 M	4.1 M	1.7 M	-	-	4.36 M	4.86 M
Long Term Debt Current	173 K	970 K	1.02 M	920 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	23.9 M	29.3 M	29.3 M	11.6 M	5.49 M	2.69 M	903 K	776 K	4.97 M	6.08 M
Total Current Liabilities	28.6 M	19.3 M	25.7 M	24.2 M	27.8 M	17.7 M	14.8 M	12.4 M	13.7 M	7.55 M	8.06 M	6.6 M
Total Liabilities	57 M	41.9 M	49.6 M	53.5 M	57.1 M	29.3 M	20.3 M	15.1 M	14.7 M	8.32 M	13 M	12.7 M
Deferred Revenue	615 K	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-11.2 M	-5.64 M	-2.13 M	1.21 M	4.75 M	11.7 M	18.6 M	19.5 M	18.8 M	16.4 M	18.5 M	12.7 M
Total Assets	92.9 M	84.5 M	96.5 M	105 M	113 M	93.2 M	93.4 M	91.9 M	95.4 M	87.6 M	98.6 M	95.5 M
Cash and Cash Equivalents	19.8 M	27 M	24.8 M	28.2 M	27.9 M	45.4 M	34.5 M	38.2 M	39.9 M	40.9 M	54.3 M	70.6 M
Book Value	36 M	42.6 M	46.9 M	51.1 M	55.6 M	63.9 M	73.1 M	76.8 M	80.8 M	79.3 M	85.6 M	82.8 M
Total Shareholders Equity	36.3 M	42.8 M	47 M	51.1 M	55.8 M	64.1 M	73.2 M	76.9 M	80.8 M	79.5 M	85.7 M	82.9 M

All numbers in USD currency

Quarterly Balance Sheet Cumberland Pharmaceuticals

	2024-Q3	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	5 M	5.1 M	5.3 M	5.39 M	5.48 M	4.55 M	4.59 M	-	-	22.7 K	90 K	230 K	512 K	789 K	1.06 M	1.06 M	1.06 M	1.06 M	2.08 M	2.32 M	2.08 M	2.61 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	52.3 M	52.5 M	52.5 M	52.1 M	52.5 M	53.4 M	57 M	52.3 M	53.3 M	55.9 M	41.9 M	40.9 M	41 M	46.5 M	49.6 M	49.6 M	49.6 M	49.6 M	53.5 M	52.1 M	53.5 M	59.4 M	57.1 M	57.1 M	57.1 M	57.1 M	29.3 M	29.3 M	29.3 M	29.3 M	20.3 M	20.3 M	20.3 M	20.3 M	15.1 M	15.1 M	15.1 M	15.1 M	14.7 M	14.7 M	14.7 M	14.7 M	8.32 M	8.32 M	8.32 M	8.32 M	13 M	13 M	13 M	13 M	12.7 M	12.7 M	12.7 M	12.7 M
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-22.1 M	-20.5 M	-17.5 M	-11.2 M	-10.1 M	-11 M	-11.2 M	-8.77 M	-8.36 M	-7.02 M	-5.64 M	-1.79 M	-736 K	-1.96 M	-2.13 M	-2.13 M	-2.13 M	-2.13 M	1.21 M	2.17 M	1.21 M	4.67 M	4.75 M	4.75 M	4.75 M	4.75 M	11.7 M	11.7 M	11.7 M	11.7 M	18.6 M	18.6 M	18.6 M	18.6 M	19.5 M	19.5 M	19.5 M	19.5 M	18.8 M	18.8 M	18.8 M	18.8 M	16.4 M	16.4 M	16.4 M	16.4 M	18.5 M	18.5 M	18.5 M	18.5 M	12.7 M	12.7 M	12.7 M	12.7 M
Total Assets	76.7 M	78.5 M	81.8 M	87.8 M	89.4 M	89.5 M	92.9 M	90.8 M	92.5 M	96.7 M	84.5 M	87.6 M	88.9 M	93.3 M	96.5 M	96.5 M	96.5 M	96.5 M	105 M	104 M	105 M	115 M	113 M	113 M	113 M	113 M	93.2 M	93.2 M	93.2 M	93.2 M	93.4 M	93.4 M	93.4 M	93.4 M	91.9 M	91.9 M	91.9 M	91.9 M	95.4 M	95.4 M	95.4 M	95.4 M	87.6 M	87.6 M	87.6 M	87.6 M	98.6 M	98.6 M	98.6 M	98.6 M	95.5 M	95.5 M	95.5 M	95.5 M
Cash and Cash Equivalents	17.5 M	17.3 M	18.3 M	18.5 M	18.2 M	16.4 M	19.8 M	19.5 M	18.2 M	17.3 M	27 M	25.8 M	25.7 M	24.9 M	24.8 M	24.8 M	24.8 M	24.8 M	28.2 M	27 M	28.2 M	24.6 M	27.9 M	27.9 M	27.9 M	27.9 M	45.4 M	45.4 M	45.4 M	45.4 M	34.5 M	34.5 M	34.5 M	34.5 M	38.2 M	38.2 M	38.2 M	38.2 M	39.9 M	39.9 M	39.9 M	39.9 M	40.9 M	40.9 M	40.9 M	40.9 M	54.3 M	54.3 M	54.3 M	54.3 M	70.6 M	70.6 M	70.6 M	70.6 M
Book Value	24.5 M	26 M	29.3 M	35.7 M	36.8 M	36 M	36 M	38.5 M	39.2 M	40.8 M	42.6 M	46.6 M	47.8 M	46.9 M	46.9 M	46.9 M	46.9 M	46.9 M	51.1 M	51.7 M	51.1 M	55.2 M	55.6 M	55.6 M	55.6 M	55.6 M	63.9 M	63.9 M	63.9 M	63.9 M	73.1 M	73.1 M	73.1 M	73.1 M	76.8 M	76.8 M	76.8 M	76.8 M	80.8 M	80.8 M	80.8 M	80.8 M	79.3 M	79.3 M	79.3 M	79.3 M	85.6 M	85.6 M	85.6 M	85.6 M	82.8 M	82.8 M	82.8 M	82.8 M
Total Shareholders Equity	24.8 M	26.3 M	29.6 M	35.7 M	36.8 M	36 M	36.3 M	38.9 M	39.2 M	40.8 M	42.8 M	46.6 M	47.8 M	46.9 M	47 M	47 M	47 M	47 M	51.1 M	51.7 M	51.1 M	55.4 M	55.8 M	55.8 M	55.8 M	55.8 M	64.1 M	64.1 M	64.1 M	64.1 M	73.2 M	73.2 M	73.2 M	73.2 M	76.9 M	76.9 M	76.9 M	76.9 M	80.8 M	80.8 M	80.8 M	80.8 M	79.5 M	79.5 M	79.5 M	79.5 M	85.7 M	85.7 M	85.7 M	85.7 M	82.9 M	82.9 M	82.9 M	82.9 M

All numbers in USD currency